Paul Biondi is jumping from Bristol-Myers to the elite team managing Flagship's startups — with newco plans of his own
Now we know what it took to lure Paul Biondi from the senior executive crew at Bristol-Myers after a 17-year stint topped by a lengthy stretch as the pharma giant’s top dealmaker.
Biondi is jumping to Flagship Pioneering as an executive partner, joining an elite executive crew that includes David Epstein and John Mendlein, after Flagship chief Noubar Afeyan wooed him to a new position spawning new biotechs and helping its growing portfolio of companies to do their own deals.
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.